Syngo NATIVE Contrast Enhanced 3D MRA on 3T Verio Magnet

Cedars-Sinai Medical Center

Status: Completed

Conditions: Vascular Disease

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02065648

CSMC-2011-MR-02-01-NATIVE-Mos

Details and patient eligibility

About

The purpose of the study is to compare non-contrast abdominal MR Angiogram (MRA) syngo NATIVE sequence performed on a 3T Verio Siemens magnet to a standard contrast-enhanced MRA performed as part of routine clinical care in patients with normal renal function to determine if the non-contrast NATIVE sequence is a viable alternative to contrast enhanced MRA in patients with renal insufficiency. There are no interventions--this is an observational study.

Full description

If the NATIVE sequence proves to be a viable alternative to contrast enhanced MRA it will provide imaging physicians with the diagnostic tool to assess vascular disease in patients with renal insufficiency without placing them at risk for additional co-morbidities.

Enrollment: 20 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Over age 18 Signed informed consent Referred for standard of care MRA

Exclusion criteria

No contra-indications for MRI/MRA ie implants which could interfere with magnets Renal insufficiency which would preclude use of contrast-enhanced contrast for a standard of care MRA

Trial design

20 participants in 1 patient group

Syngo NATIVE MRA

Description:

All consenting participants will receive an additional non-contrast Syngo NATIVE MRA sequence prior to contrast injection their standard of care MRA.